Anti-Phosphoserine Antibody

(No reviews yet) Write a Review
SKU:
STPA00021
Antibody Type:
Polyclonal
Applications:
WB
Applications:
IHC
Applications:
ICC/IF
Applications:
IP
Applications:
ELISA
Reactivity:
Species Independent
Host Species:
Rabbit
  • Immunocytochemistry/Immunofluorescence analysis using Rabbit Anti-Phosphoserine Polyclonal Antibody (STPA00021). Tissue: Cervical cancer cell line (HeLa). Species: Human. Fixation: 2% Formaldehyde for 20 min at RT. Primary Antibody: Rabbit Anti-Phosphoserine Polyclonal Antibody (STPA00021) at 1:50 for 12 hours at 4°C. Secondary Antibody: R-PE Goat Anti-Rabbit (yellow) at 1:200 for 2 hours at RT.
  • Western blot analysis of Mouse Spleen lysates showing detection of Phosphoserine protein using Rabbit Anti-Phosphoserine Polyclonal Antibody (STPA00021). Primary Antibody: Rabbit Anti-Phosphoserine Polyclonal Antibody (STPA00021) at 1:1000. Bands are responsive to treatment with varying long UV wavelengths: A(0), B(50), C(200), D(400), and E (treated with 0.1µM okadaic acid).
Frequently bought together:

Description

Phosphoserine Antibody

Phosphoserine Antibody is a rabbit polyclonal antibody directed against Phosphoserine, offered by Assay Genie for research applications. Reported applications include WB, IHC, ICC/IF, IP and ELISA. Reactivity is species independent. Purified by Peptide Affinity.

Phosphoserine is a post-translationally modified form of the amino acid serine, resulting from phosphorylation by serine/threonine kinases. This modification plays a critical role in regulating protein function, localization, and interactions, particularly in the central nervous system. In neurons, phosphoserine is involved in signal transduction, synaptic plasticity, and cytoskeletal dynamics. Aberrant serine phosphorylation has been implicated in the pathogenesis of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS. For example, hyperphosphorylation of tau protein at serine residues contributes to neurofibrillary tangle formation and neuronal dysfunction in Alzheimer’s disease. Phosphoserine also modulates the activity of transcription factors, ion channels, and enzymes involved in oxidative stress responses and apoptosis. As a dynamic and reversible modification, it offers a promising target for therapeutic intervention and biomarker development in neurodegeneration. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, Biotin and FITC. Supplied in 400 µl. For research use only; not for diagnostic or therapeutic procedures.

View AllClose

0 Reviews

View AllClose